Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension

This publication has 25 references indexed in Scilit:

• The common -675 4G/5G polymorphism in the plasminogen activator inhibitor –1 gene is strongly associated with obesity
  Diabetologia, 2002
• Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Does Hypertension Confer a Prothrombotic State?
  Circulation, 2000
• Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• The 4G4G Genotype of the Plasminogen Activator Inhibitor 4G/5G Gene Polymorphism Is Associated with Coronary Atherosclerosis in Patients at High Risk for this Disease
  Thrombosis and Haemostasis, 1999
• Concentration of Endogenous tPA Antigen in Coronary Artery Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Relationship Between Endothelial Function and Fibrinolysis in Early Hypertension
  Hypertension, 1998
• Fibrinogen Plasma Levels in an Apparently Healthy General Population – Relation to Environmental and Genetic Determinants
  Thrombosis and Haemostasis, 1998
• Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Stroke Patients
  Stroke, 1996
• European Atherosclerosis Research Study: Genotype at the Fibrinogen Locus (G ₋₄₅₅ -A β-Gene) Is Associated With Differences in Plasma Fibrinogen Levels in Young Men and Women From Different Regions in Europe
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995